Literature DB >> 23497867

AKT signalling and mitochondrial pathways are involved in mushroom polysaccharide-induced apoptosis and G1 or S phase arrest in human hepatoma cells.

Fengju OuYang1, Guibin Wang, Wei Guo, Yuanyuan Zhang, Wenhua Xiang, Min Zhao.   

Abstract

This study describes molecular mechanisms for inhibiting tumour cell proliferation using polysaccharides from medicinal mushrooms in human hepatoma cells. The results show that regarding cell cycle-related proteins, three types of polysaccharides significantly enhance the expression of p27(Kip) in HepG2 and Bel-7404 cells, while suppressing the activity of cyclin D1/CDK4 and/or cyclin E/CDK2. Considering apoptosis-related factors, the polysaccharides suppressed AKT activity through the inhibition of AKT phosphorylation at Thr(308) and/or Ser(473). The growth of HepG2 and Bel-7404 cells was suppressed by the up-regulation of a subunit of PI3K and phospho-PTEN, which are modulators of AKT activity. The polysaccharides also activated the mitochondria-mediated apoptosis pathway by stimulating the activation of Bcl-2 family proteins to release cytochrome c and Smac and cleave caspase-9 and caspase-3 in HepG2 and Bel-7404 cells. These factors have a potent effect on cell cycle arrest in G(1) and/or S phase and induce apoptosis in HepG2 and Bel-7404 cells. Crown
Copyright © 2012. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23497867     DOI: 10.1016/j.foodchem.2012.10.047

Source DB:  PubMed          Journal:  Food Chem        ISSN: 0308-8146            Impact factor:   7.514


  9 in total

Review 1.  Proteomic Research on the Antitumor Properties of Medicinal Mushrooms.

Authors:  Boris Jakopovic; Nada Oršolić; Ivan Jakopovich
Journal:  Molecules       Date:  2021-11-05       Impact factor: 4.411

Review 2.  Mushroom Polysaccharide-Assisted Anticarcinogenic Mycotherapy: Reviewing Its Clinical Trials.

Authors:  Iyyakkannu Sivanesan; Manikandan Muthu; Judy Gopal; Jae-Wook Oh
Journal:  Molecules       Date:  2022-06-25       Impact factor: 4.927

Review 3.  A Preclinical Evaluation of the Antitumor Activities of Edible and Medicinal Mushrooms: A Molecular Insight.

Authors:  Thomson Patrick Joseph; Warren Chanda; Arshad Ahmed Padhiar; Samana Batool; Shao LiQun; MinTao Zhong; Min Huang
Journal:  Integr Cancer Ther       Date:  2017-11-02       Impact factor: 3.279

4.  Antioxidant Activity and Neuroprotective Activity of Stilbenoids in Rat Primary Cortex Neurons via the PI3K/Akt Signalling Pathway.

Authors:  Haichao Wen; Zheng Fu; Yangji Wei; Xiaoxu Zhang; Liyan Ma; Liwei Gu; Jingming Li
Journal:  Molecules       Date:  2018-09-12       Impact factor: 4.411

5.  Comparative transcriptome analysis reveals relationship of three major domesticated varieties of Auricularia auricula-judae.

Authors:  Yuhui Zhao; Liang Wang; Dongshan Zhang; Rong Li; Tianyou Cheng; Yibi Zhang; Xueju Liu; Gary Wong; Yuguo Tang; Hui Wang; Shan Gao
Journal:  Sci Rep       Date:  2019-01-11       Impact factor: 4.379

Review 6.  Antioxidant Versus Pro-Apoptotic Effects of Mushroom-Enriched Diets on Mitochondria in Liver Disease.

Authors:  Adriana Fontes; Mireia Alemany-Pagès; Paulo J Oliveira; João Ramalho-Santos; Hans Zischka; Anabela Marisa Azul
Journal:  Int J Mol Sci       Date:  2019-08-16       Impact factor: 5.923

7.  Immunomodulatory activity of polysaccharides from Brassica rapa by activating Akt/NF-κB signaling.

Authors:  Weiwei Guo; Qianxiao Zhang; Yu Du; Junting Guo; Tingting Zhao; Liping Bai; Xiqiang An
Journal:  Chin Herb Med       Date:  2021-10-07

8.  A proteomic analysis of mushroom polysaccharide-treated HepG2 cells.

Authors:  Yangyang Chai; Guibin Wang; Lili Fan; Min Zhao
Journal:  Sci Rep       Date:  2016-03-29       Impact factor: 4.379

9.  Protocatechualdehyde Induces S-Phase Arrest and Apoptosis by Stimulating the p27(KIP1)-Cyclin A/D1-CDK2 and Mitochondrial Apoptotic Pathways in HT-29 Cells.

Authors:  Shi Zhong; You-Gui Li; Dong-Feng Ji; Tian-Bao Lin; Zhi-Qiang Lv
Journal:  Molecules       Date:  2016-07-19       Impact factor: 4.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.